Navin Fluorine International Limited — Investor Meet, 17-12-2024: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:**

Navin Fluorine International reported Q2 FY25 revenues of ₹518.6 Cr, marking a 10% year-over-year increase, but down 1% sequentially. Operating EBITDA reached ₹107.4 Cr, up 9% YoY, with an EBITDA margin of 20.7%, slightly lower by 14 bps compared to the previous year. For the first half of FY25, revenue totaled ₹1,042.2 Cr, an 8% YoY growth, but operating EBITDA declined by 2%, resulting in a margin of 19.9%, down 215 bps YoY.

**Future Outlook and Growth Drivers:**

Management highlighted a strategic focus on expanding R32 production, expecting significant demand for high-performance products. New capacities at the Dahej and Surat facilities, along with the introduction of additional product lines, are expected to boost revenue in the upcoming quarters.

**Order Book and Operational Updates:**

A strong order visibility is noted for the second half of FY25, particularly from the Surat and Dahej assets. Notable contracts include a multi-year supply agreement in agrochemicals funded by ₹450 Cr capex, on track for commissioning by FY26.

**Analyst Q&A Insights:**

Management addressed questions regarding revenue growth, indicating expectations shaped by robust demand in the specialty chemical segment despite global macroeconomic challenges. Analysts probed into profitability pressures, especially regarding costs; the management expressed confidence in mitigating supply chain challenges. Projections suggest continued resilience in earnings and a strategic pivot towards higher-margin products.

**Market or Regulatory Updates:**

There were no significant market or regulatory shifts discussed that would impact short-term operational performance, although global industry conditions remain a focal point.

**Strategic Focus Areas:**

The company is committed to sustainability initiatives, targeting 30% reduction in carbon emissions by 2030, along with heightened diversity in workforce and leadership roles.

**Investor Insight:**

With a robust financial health, a solid growth trajectory underpinned by strategic investments, and an optimistic management outlook, the current momentum suggests a favorable position for further upside, aligning with a ‘buy’ stance for retail investors. The potential risks from macroeconomic factors remain, but the company’s proactive strategic moves position it well against these challenges.